Friends of Cancer Research is proud to host our yearly Annual Meeting to address critical issues in the development of new oncology drugs. Each meeting brings together leaders in cancer drug development from federal health and regulatory agencies, academic research, the private sector, and patient advocates for focused discussions on key issues surrounding the development and regulation of cancer drugs and therapies. The meeting will features panels and experts that will propose unique approaches toward current challenges in drug development.
Click the links below for summaries and documents from past Friends Annual Meetings.
A Unique Model to Advance Biomedical Research
Each year Friends of Cancer Research (Friends) and the Engelberg Center for Health Care Reform at Brookings convene the Conference on Clinical Cancer Research to address critical issues in the development of new drugs. This annual conference brings together leaders from federal health and regulatory agencies, academic research centers, patient advocacy organizations and the private sector to propose consensus solutions and develop a clear path forward on critical issues surrounding the development and regulation of drugs and therapies.
Through our unique collaborative model, we have created a path to better drug development and approval through scientific, cultural, regulatory and legislative solutions. Our reports have been published in 10 peer-reviewed scientific journals and featured in major news and trade publications.